Clinical trial
Chemotherapy and Radiotherapy for Osteolymphoma
NCT00141648 · Trans Tasman Radiation Oncology Group, Other · Completed
Key facts
| NCT number | NCT00141648 |
|---|---|
| Title | Chemotherapy and Radiotherapy for Osteolymphoma |
| Official title | A Prospective Non-randomised Trial of Chemotherapy and Radiotherapy for Osteolymphoma |
| Lead sponsor | Trans Tasman Radiation Oncology Group, Other |
| Collaborators | Australasian Leukaemia and Lymphoma Group Australasian Radiation Oncology Lymphoma Group Wesley Research Institute |
| Status | Completed |
| Study type | Interventional |
| Conditions | Osteolymphoma |
| Intervention type | Drug, Radiation |
| Interventions | Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone., Radiotherapy |
| Enrollment | 70 |
| Start date | Sep 1, 2000 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Sep 1, 2005 |
| Last update posted | Oct 1, 2009 |
| Countries | Australia, New Zealand |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: